multicenter clinical trial investigating spesolimab (Boehringer Ingelheim)
86
Structured Review
Boehringer Ingelheim
multicenter clinical trial investigating spesolimab
Multicenter Clinical Trial Investigating Spesolimab, supplied by Boehringer Ingelheim, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/multicenter+clinical+trials/clinical+identification+trial/pm41723100-361-18-8
Average 86 stars, based on 1 article reviews
Multicenter Clinical Trial Investigating Spesolimab, supplied by Boehringer Ingelheim, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/multicenter+clinical+trials/clinical+identification+trial/pm41723100-361-18-8
Average 86 stars, based on 1 article reviews
multicenter clinical trial investigating spesolimab - by Bioz Stars,
2026-10
86/100 stars
Images
Related Articles
Clinical Proteomics:Article Title: Effect of fluticasone propionate/salmeterol (250/50) on COPD exacerbations and impact on patient outcomes. Article Snippet: Prevention and treatment of COPD exacerbations are recognized as key goals in disease management.. This randomized, double-blind, parallel-group, multicenter study evaluated the effect of fluticasone propionate/salmeterol 250 mcg/50 mcg (FSC 250/50) and salmeterol 50 mcg (SAL) twice-daily on moderate/severe exacerbations.. Subjects received treatment with FSC 250/50 during a one month run-in, followed by randomization to FSC 250/50 or SAL for 52 weeks. Article Title: Medication adherence in young adults with youth-onset type 2 diabetes: iCount, an observational study. Article Snippet: .. Declaration of Competing Interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: |